Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms

Viz.ai has signed an exclusive agreement with the University of California, San Francisco (UCSF) to commercialize three AI algorithms for the automated detection of cardiovascular diseases.

yahoo.com

Relevant topic timeline:

8/22/2023

New York's largest health system is pushing into generative AI with help from a former Amazon exec and a $100 million venture partnership

Northwell Health, New York's largest health system, is partnering with Aegis Ventures to develop generative AI products that aim to reduce the burden of paperwork and administrative tasks for healthcare providers.

8/27/2023

Groundbreaking AI-Method Finds a Way to People’s Hearts

Scientists have developed an AI model that accurately identifies cardiac functions and valvular heart diseases using chest radiographs, which could improve diagnostic efficiency and be useful in settings lacking specialized technicians.

9/6/2023

Fox News AI Newsletter: Artificial intelligence-generated COVID drug enters clinical trials

An AI-generated COVID drug enters clinical trials, GM and Google strengthen their AI partnership, and Israel unveils an advanced AI-powered surveillance plane, among other AI technology advancements.

9/7/2023

Will AI Replace Cardiologists and Turn Them Into Managers?

Artificial intelligence (AI) is changing the field of cardiology, but it is not replacing cardiologists; instead, it is seen as a tool that can enhance efficiency and improve patient care, although it requires medical supervision and has limitations.